Geode Capital Management’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,678
Closed -$45.1K 4808
2023
Q2
$45.1K Hold
3,678
﹤0.01% 4527
2023
Q1
$52.7K Hold
3,678
﹤0.01% 4505
2022
Q4
$55K Sell
3,678
-9
-0.2% -$259 ﹤0.01% 4571
2022
Q3
$143K Buy
3,687
+881
+31% +$50.6K ﹤0.01% 4385
2022
Q2
$214K Sell
2,806
-102
-4% -$8.95K ﹤0.01% 4218
2022
Q1
$141K Buy
2,908
+227
+8% +$13.6K ﹤0.01% 4526
2021
Q4
$187K Buy
2,681
+388
+17% +$41.8K ﹤0.01% 4506
2021
Q3
$334K Buy
2,293
+27
+1% +$8.19K ﹤0.01% 4214
2021
Q2
$1.39M Buy
2,266
+2,002
+758% +$1.31M ﹤0.01% 3438
2021
Q1
$184K Buy
+264
New +$190K ﹤0.01% 4138

Other funds holding MDVL

Geode Capital Management's MDVL Position: Q3 2023 in Review

Geode Capital Management sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 3,678 shares — an estimated $45.1K sold.

Geode Capital Management first reported a position in MDVL in Q1 2021 and held it in 10 quarters. The position peaked at $1.39M in Q2 2021. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

  • Geode Capital Management reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 3,678 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $45.1K.
  • Geode Capital Management first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Geode Capital Management's MedAvail Holdings, Inc. Common Stock position peaked at $1.39M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.